Noncoding RNA Modulation for Cardiovascular Therapeutics
Significances of Bioengineering & Biosciences · 2018
DOI: 10.31031/sbb.2018.01.000513 ↗Kurz gefasst
Fachartikel in der Zeitschrift Significances of Bioengineering & Biosciences, 2018. Verfasst von Ki-Chul Hwang.
Abstract (Originalsprache)
Cardiovascular diseasesare multifactorial diseases that involve alteration of multiple genes and subsequent phenotypic changes. Non-coding RNAs regulate gene expression, affecting many physiological and pathophysiological processes in humans. Accumulating evidence indicates that noncoding RNA, such as microRNAs, expression profile changes can lead to cardiovascular diseases. This article reviews the current findings regarding the roles of noncoding RNAs in cardiovascular diseases, and strategy to modulate them for therapeutics.
Zitieren
APA
Hwang, K. (2018). Noncoding RNA Modulation for Cardiovascular Therapeutics. Significances of Bioengineering & Biosciences. https://doi.org/10.31031/sbb.2018.01.000513
Vancouver
Hwang K. Noncoding RNA Modulation for Cardiovascular Therapeutics. Significances of Bioengineering & Biosciences. 2018. doi:10.31031/sbb.2018.01.000513
BibTeX
@article{Hwang2018,
author = {Hwang, Ki-Chul},
title = {Noncoding RNA Modulation for Cardiovascular Therapeutics},
journal = {Significances of Bioengineering & Biosciences},
year = {2018},
doi = {10.31031/sbb.2018.01.000513}
}
EUVIMED